处方阿片类药物治疗慢性疼痛患者中处方阿片使用障碍的诊断
研究纳入606例来自疼痛诊所和住院物质治疗机构、曾接受≥30天阿片类药物处方治疗慢性疼痛的患者,评估DSM-5处方阿片使用障碍(POUD)与疼痛调整POUD(若疼痛缓解为唯一动机则不记为阳性)的有效性。结果显示疼痛调整提高了所有效标与POUD的关联强度,疼痛调整对物质治疗患者患病率影响小,但对疼痛治疗患者患病率大幅降低。
要点
- 疼痛调整后POUD患病率在疼痛治疗患者中大幅降低,在物质治疗患者中影响小。
- 所有效标与疼痛调整维度POUD的关联均显著强于DSM-5维度POUD(均值比比值1.22-2.31)。
- 多数效标中,疼痛调整二分POUD的比值比大于DSM-5测量。
核心结论
- 根据疼痛缓解(治疗意图)调整POUD测量提高了有效性。
研究设计与样本
- 研究纳入606例来自疼痛诊所和住院物质治疗机构、曾接受≥30天阿片类药物处方治疗慢性疼痛的患者。
- 评估DSM-5 POUD(按DSM-5指南,仅按处方使用阿片时不将戒断和耐受记为阳性)和疼痛调整POUD(若疼痛缓解为唯一动机,行为/主观标准不记为阳性)。
- 采用双变量相关结局回归模型分析10个效标与DSM-5及疼痛调整POUD测量的关联,维度测量用均值比,二分测量用比值比。
主要发现
- DSM-5 POUD和疼痛调整POUD在≥2条标准阈值下的患病率分别为44.4%和30.4%,在≥4条标准阈值下分别为29.5%和25.3%。
- 疼痛调整对物质治疗患者患病率影响小,但使疼痛治疗患者患病率大幅降低。
- 所有效标与疼痛调整维度POUD的关联均显著强于与DSM-5维度POUD的关联(均值比的比值1.22-2.31)。
- 对于多数效标,疼痛调整二分POUD的比值比大于DSM-5测量的比值比。
临床怎么用
- 研究提示在评估POUD诊断标准时,区分治疗意图与非治疗意图可能具有临床效用,尚需研究进一步探讨。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The diagnostic criteria for opioid use disorder, originally developed for heroin, did not anticipate the surge in prescription opioid use and the resulting complexities in diagnosing prescription opioid use disorder (POUD), including differentiation of pain relief (therapeutic intent) from more common drug use motives, such as to get high or to cope with negative affect. The authors examined the validity of the Psychiatric Research Interview for Substance and Mental Disorders, DSM-5 opioid version, an instrument designed to make this differentiation. METHODS: Patients (N=606) from pain clinics and inpatient substance treatment who ever received a ≥30-day opioid prescription for chronic pain were evaluated for DSM-5 POUD (i.e., withdrawal and tolerance were not considered positive if patients used opioids only as prescribed, per DSM-5 guidelines) and pain-adjusted POUD (behavioral/subjective criteria were not considered positive if pain relief [therapeutic intent] was the sole motive). Bivariate correlated-outcome regression models indicated associations of 10 validators with DSM-5 and pain-adjusted POUD measures, using mean ratios for dimensional measures and odds ratios for binary measures. RESULTS: The prevalences of DSM-5 and pain-adjusted POUD, respectively, were 44.4% and 30.4% at the ≥2-criteria threshold and 29.5% and 25.3% at the ≥4-criteria threshold. Pain adjustment had little effect on prevalence among substance treatment patients but resulted in substantially lower prevalence among pain treatment patients. All validators had significantly stronger associations with pain-adjusted than with DSM-5 dimensional POUD measures (ratios of mean ratios, 1.22-2.31). For most validators, pain-adjusted binary POUD had larger odds ratios than DSM-5 measures. CONCLUSIONS: Adapting POUD measures for pain relief (therapeutic intent) improved validity. Studies should investigate the clinical utility of differentiating between therapeutic and nontherapeutic intent in evaluating POUD diagnostic criteria.
引用
- Hasin DS, Shmulewitz D, Stohl M, et al. Diagnosing Prescription Opioid Use Disorder in Patients Using Prescribed Opioids for Chronic Pain. Am J Psychiatry. 2022. PMID: 35702830. doi:10.1176/appi.ajp.21070721
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。